Literature DB >> 24985196

West Nile encephalitis outbreak in Kerala, India, 2011.

B Anukumar1, Gajanan N Sapkal2, Babasheb V Tandale3, R Balasubramanian4, Daya Gangale5.   

Abstract

BACKGROUND: An outbreak of acute encephalitis syndrome (AES) was reported in Kerala in India in May 2011. The outbreak features were unusual in terms of seasonality, geographical distribution, age group, and clinical manifestations in comparison to the epidemiological features of Japanese Encephalitis.
OBJECTIVE: To detect the etiology of the acute encephalitis syndrome outbreak. STUDY
DESIGN: Investigation of outbreak was undertaken by collection of brief clinical history and epidemiological details along with the specimens for viral diagnosis. The serum/CSF samples (patients=208) received from the sentinel hospitals were subjected to IgM capture ELISA and RT-PCR specific for Japanese encephalitis (JE) virus and West Nile virus (WNV). The JE/WN IgM positive samples were further tested by serum neutralization assay for the presence of JE and WNV specific neutralizing antibody. RESULT: Most of the affected patients were aged above 15 years. No spatial clustering of the disease was noticed. Cases were observed in premonsoon and early monsoon season and in JE non-endemic area of Kerala. A total of 47 patient samples were positive for in-house JE IgM capture ELISA and WNV IgM capture ELISA. Serum neutralization assay result revealed that 32 of 42 (76.19%) sera were positive for WNV neutralization antibodies. WNV was isolated from a clinical specimen. Phylogenetic analysis of WNV envelope gene revealed 99% homology with Russian Lineage 1 WNV.
CONCLUSION: West Nile virus (WNV) etiology was confirmed by virus isolation and detection of virus specific antibody from clinical specimen. Phylogenetic analysis grouped the current strain in lineage I West Nile virus.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute encephalitis syndrome; Disease outbreak; Flavivirus; India; Kerala; Lineage I West Nile virus

Mesh:

Substances:

Year:  2014        PMID: 24985196     DOI: 10.1016/j.jcv.2014.06.003

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  21 in total

1.  A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice.

Authors:  Na Li; Zhe-Rui Zhang; Ya-Nan Zhang; Jing Liu; Cheng-Lin Deng; Pei-Yong Shi; Zhi-Ming Yuan; Han-Qing Ye; Bo Zhang
Journal:  NPJ Vaccines       Date:  2020-08-05       Impact factor: 7.344

2.  Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.

Authors:  Na Li; Ya-Nan Zhang; Cheng-Lin Deng; Pei-Yong Shi; Zhi-Ming Yuan; Bo Zhang
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

Review 3.  Diagnosis and Management of Acute Encephalitis in Children.

Authors:  Satinder Aneja; Suvasini Sharma
Journal:  Indian J Pediatr       Date:  2018-09-19       Impact factor: 5.319

4.  Seroprevalence of Japanese encephalitis virus & West Nile virus in Alappuzha district, Kerala.

Authors:  Anukumar Balakrishnan; Romy Jose Thekkekare; Gajanan Sapkal; Babasaheb V Tandale
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

5.  Clinical Features of Four West Nile Virus Cases and Its Molecular Characterization from a South Indian Tertiary Care Hospital.

Authors:  Shoba Mammen; Aiswarya Nair; Santhosh Kumar; Zayina Zonderveni; A T Prabhakar; Turaka Vijay Prakash; Sanjith Aaron; Mathew Alexander; Anand Zachariah; Asha Mary Abraham
Journal:  Case Rep Infect Dis       Date:  2020-07-16

6.  Immunoinformatics and molecular dynamics approaches: Next generation vaccine design against West Nile virus.

Authors:  Md Tahsin Khan; Rahatul Islam; Tarhima Jahan Jerin; Araf Mahmud; Sahara Khatun; Ahasanul Kobir; Md Nahidul Islam; Arzuba Akter; Shakhinur Islam Mondal
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

7.  Emergence of human West Nile Virus infection in Sri Lanka.

Authors:  Janarthani Lohitharajah; Gathsaurie Neelika Malavige; Anthony Jin Shun Chua; Mah Lee Ng; Carukshi Arambepola; Thashi Chang
Journal:  BMC Infect Dis       Date:  2015-07-31       Impact factor: 3.090

Review 8.  Cryptic etiopathological conditions of equine nervous system with special emphasis on viral diseases.

Authors:  Rakesh Kumar; Rajendra D Patil
Journal:  Vet World       Date:  2017-12-10

9.  A need to raise the bar - A systematic review of temporal trends in diagnostics for Japanese encephalitis virus infection, and perspectives for future research.

Authors:  Tehmina Bharucha; Freya M Shearer; Manivanh Vongsouvath; Mayfong Mayxay; Xavier de Lamballerie; Paul N Newton; Nicole Zitzmann; Ernest Gould; Audrey Dubot-Pérès
Journal:  Int J Infect Dis       Date:  2020-03-20       Impact factor: 3.623

10.  A replication-defective Japanese encephalitis virus (JEV) vaccine candidate with NS1 deletion confers dual protection against JEV and West Nile virus in mice.

Authors:  Na Li; Zhe-Rui Zhang; Ya-Nan Zhang; Jing Liu; Cheng-Lin Deng; Pei-Yong Shi; Zhi-Ming Yuan; Han-Qing Ye; Bo Zhang
Journal:  NPJ Vaccines       Date:  2020-08-05       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.